AlloSure now available for Lung Transplant Patients
AlloSure Lung is the next addition to the
“There is an incredible unmet need for blood based surveillance in this patient population,” said
“I am glad to see the donor derived cell free DNA technology become broadly available for clinical care of lung transplant patients,” said
For more information, please visit: www.CareDx.com.
Forward Looking Statements
This press release includes forward-looking statements, including statements regarding the availability of AlloSure under a compassionate use program for lung transplant patients. These forward-looking statements are based upon information that is currently available to
Chief Commercial Officer
Integrated Corporate Relations, Inc.
Source: CareDx, Inc.